title: Erlotinib induced trichomegaly of the eyelashes.
abstract: Epithelial growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been widely used for non-small-cell lung cancer patients. Its untoward cutaneous effects are largely well known and developed in many patients treated with EGFR TKIs. However trichomegaly of eyelash is rarely reported. Although trichomegaly is not a drug-limiting side effect, it could be troublesome of continuing the treatment because of cosmetic issue or eyeball irritation by long eyelashes. Therefore clinicians are needed to pay attention to this uncommon effect. We herein describe erlotinib induced trichomegaly of eyelashes in a woman with adenocarcinoma of the lung.
authors: Department of Internal Medicine, Inha University College of Medicine, Incheon, Korea.
authors: Sang-Hoon
authors: SH
authors: Jeon
authors: Jeong-Seon
authors: JS
authors: Ryu
authors: Gwang-Seong
authors: GS
authors: Choi
authors: Jung-Soo
authors: JS
authors: Kim
authors: Hea-Yoon
authors: HY
authors: Kwon
authors: Min-Su
authors: MS
authors: Kim
authors: Hae-Seong
authors: HS
authors: Nam
authors: Jae-Hwa
authors: JH
authors: Cho
authors: Seung-Min
authors: SM
authors: Kwak
authors: Hong Lyeol
authors: HL
authors: Lee
authors: Hyun-Jung
authors: HJ
authors: Kim
authors: Geun-Jeong
authors: GJ
authors: Hong
keywords: Erlotinib; Eyelashes; Lung Neoplasms; Physiological Effects of Drugs; Receptor, Epidermal Growth Factor
references: Eur J Cancer. 2009 Jan;45(2):228-47
references: 19097774
references: J Clin Oncol. 2008 Jul 10;26(20):3460-2
references: 18612164
references: Br J Dermatol. 2004 Nov;151(5):1111-2
references: 15541102
references: J Clin Oncol. 2002 Jan 1;20(1):110-24
references: 11773160
references: J Clin Oncol. 2005 Jan 1;23(1):165-74
references: 15557594
references: J Thorac Oncol. 2009 Jun;4(6):684-8
references: 19404216
references: Ophthalmic Plast Reconstr Surg. 2007 Jan-Feb;23(1):65-6
references: 17237698
references: J Thorac Oncol. 2006 Nov;1(9):1040-1
references: 17409992
references: Br J Dermatol. 2001 Jun;144(6):1169-76
references: 11422037
references: J Clin Oncol. 2004 Aug 15;22(16):3238-47
references: 15310767
references: Ann Oncol. 2005 Oct;16(10):1711-2
references: 15972283